These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23127309)

  • 41. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Gail MH
    J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of breast cancer risk among women of the Mariana Islands: the BRISK retrospective case-control study.
    Shvetsov YB; Wilkens LR; White KK; Chong M; Buyum A; Badowski G; Leon Guerrero RT; Novotny R
    BMJ Open; 2022 Dec; 12(12):e061205. PubMed ID: 36600333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.
    Laitman Y; Simeonov M; Keinan-Boker L; Liphshitz I; Friedman E
    Genet Res (Camb); 2013 Dec; 95(6):174-7. PubMed ID: 24506973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman.
    Paige JS; Lee CI; Wang PC; Hsu W; Brentnall AR; Hoyt AC; Naeim A; Elmore JG
    J Gen Intern Med; 2023 Aug; 38(11):2584-2592. PubMed ID: 36749434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study.
    Brooks JD; Mah A; Christensen RAG; Arneja J; Eisen A; Chiarelli AM
    Genet Med; 2023 Jun; 25(6):100820. PubMed ID: 36919844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model for individualized prediction of breast cancer risk after a benign breast biopsy.
    Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC
    J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
    Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
    Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting breast cancer risk in a racially diverse, community-based sample of potentially high-risk women.
    Meadows RJ; Figueroa W; Shane-Carson KP; Padamsee TJ
    Cancer Med; 2022 Nov; 11(21):4043-4052. PubMed ID: 35388639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.
    Lo LL; Milne RL; Liao Y; Cuzick J; Terry MB; Phillips KA
    Br J Cancer; 2018 Jul; 119(1):36-39. PubMed ID: 29925933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes.
    McCarthy AM; Liu Y; Ehsan S; Guan Z; Liang J; Huang T; Hughes K; Semine A; Kontos D; Conant E; Lehman C; Armstrong K; Braun D; Parmigiani G; Chen J
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
    MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
    J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
    Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
    JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
    Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
    Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women.
    Bener A; Çatan F; El Ayoubi HR; Acar A; Ibrahim WH
    J Prim Care Community Health; 2017 Jul; 8(3):180-187. PubMed ID: 28606030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
    Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
    Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
    BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.